Market Cap (In USD)
3.25 Million
Revenue (In USD)
3.02 Million
Net Income (In USD)
-8.03 Million
Avg. Volume
178.32 Thousand
- Currency
- USD
- Country
- Healthcare
- Open
- -
- Prev. Close
- -
- Day Range
- -
- Year Range
- 0.63-3.5
- PE
- -
- EPS
- -
- Beta Value
- 1.436
- ISIN
- US44984F4019
- CUSIP
- 44984F302
- CIK
- 1417926
- Shares
- -
- Earnings Annoncement
- -
Company Profile
- Sector
- Healthcare
- Industry
- Medical - Devices
- CEO
- Mr. Steven M. Shum
- Employee Count
- -
- Website
- https://www.invobio.com
- Ipo Date
- 2020-11-02
- Details
- INVO Bioscience, Inc., a commercial-stage fertility company, provides assisted reproductive technology solutions worldwide. Its flagship product is the INVOcell, a medical device that allows fertilization and early embryo development to take place in vivo within the woman's body. The company was founded in 2007 and is based in Sarasota, Florida.
More Stocks
-
CBAN
-
0L7F
-
MRG
-
4832JFE Systems, Inc.
4832
-
6809TOA Corporation
6809
-
IWGIWG plc
IWG
-
9245Livero Inc.
9245
-
CINF